Trials / Completed
CompletedNCT01754818
A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131)
Phase 1 Randomized, Double-blind, Placebo-controlled Study of The Safety, Tolerability and Pharmacokinetics of Single, Ascending Oral Doses Of Bendavia in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Stealth BioTherapeutics Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the study medication blood levels after administration of a single oral capsule of Bendavia at one of three dose levels. The effects of Bendavia on the volunteers will also be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bendavia 10mg | |
| DRUG | Bendavia 50mg | |
| DRUG | Bendavia 100mg | |
| DRUG | Placebo |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2013-01-01
- Completion
- 2013-02-01
- First posted
- 2012-12-21
- Last updated
- 2013-02-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01754818. Inclusion in this directory is not an endorsement.